Abbott Laboratories (ABT)

Total Assets

$109.22B

Quarterly · Period ending: · USD

ABT logo

ABT Total Assets

Latest reported$109.22B
ABT Quarterly Total Assets ($3.47B → $109.22B)
High-resolution chart · PNG

ABT total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
109,215,000,000
110,429,000,000
86,713,000,000
84,181,000,000
83,999,000,000
81,448,000,000
81,414,000,000
74,356,000,000
73,017,000,000
72,467,000,000
73,214,000,000
72,090,000,000
73,354,000,000
73,794,000,000
74,438,000,000
72,801,000,000
74,202,000,000
74,007,000,000
75,196,000,000
73,795,000,000
73,269,000,000
72,785,000,000
72,548,000,000
69,043,000,000
68,776,000,000
66,777,000,000
67,887,000,000
68,539,000,000
68,427,000,000
67,610,000,000
67,173,000,000
71,637,000,000
68,415,000,000
70,908,000,000
76,250,000,000
72,248,000,000
71,151,000,000
70,887,000,000
55,011,000,000
39,497,000,000
39,831,000,000
39,637,000,000
41,247,000,000
41,725,000,000
44,125,000,000
43,095,000,000
41,275,000,000
42,514,000,000
41,475,000,000
41,662,000,000
42,953,000,000
44,132,477,000
42,903,346,000
42,686,613,000
67,234,944,000
63,257,738,000
61,859,790,000
62,415,801,000
60,276,893,000
59,628,176,000
62,004,241,000
61,651,363,000
59,462,266,000
57,373,620,000
53,381,402,000
53,358,622,000
52,416,623,000
49,846,820,000
47,630,017,000
45,437,597,000
42,419,204,000
41,753,012,000
44,073,719,000
41,177,572,000
39,713,924,000
37,621,909,000
37,153,222,000
36,286,117,000
36,178,172,000
33,299,872,000
34,061,267,000
28,531,500,000
29,141,203,000
28,830,959,000
27,817,213,000
28,857,214,000
28,767,494,000
27,564,226,000
27,686,181,000
28,053,333,000
26,715,342,000
26,154,769,000
25,890,854,000
24,882,580,000
24,259,102,000
23,660,355,000
23,053,101,000
22,765,776,000
23,296,423,000
22,719,399,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.